EMS 12-Lead
MARCH 30, 2024
TCP In Transit: A case reviewing transcutaneous pacing, false electrical capture, and re-arrest. Josh Kimbrell, NRP @joshkimbre Judah Kreinbrook, EMT-P @JMedic2JDoc This is the first installment of a blog series showing how transcutaneous pacing (TCP) can be difficult, and how you can improve your skills. We will be using redacted information from different cases where paramedics attempted TCP in the field.
Med Page Today
MARCH 30, 2024
(MedPage Today) -- About 25 million people stand to gain from the FDA's recent approval of the first over-the-counter continuous glucose monitor (CGM). That means fewer finger pricks and greater access for patients with type 2 diabetes who do not.
HCPLive
MARCH 30, 2024
In this episode, Alan Lotvin, MD, of Sequel Med Tech, joins hosts for a deep dive into the twiist automated insulin delivery system, which received clearance for people with T1D in March 2024.
Dr. Paddy Barrett
MARCH 30, 2024
The opportunity to engage with over 20,000 people every week with this newsletter is one of the most impactful things I have ever done. For that. I have YOU to thank. Enrolment in the Heart Health Formula closed last week, and the feedback has been great. For those of you who are not enrolled, I have a favour to ask. If you could answer a few questions, it would really help me provide value to you in the future.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HCPLive
MARCH 30, 2024
Abusing psychoactive substances, such as ADHD medication, cannabis, and nicotine, not only creates an addiction but can impact mental distress.
All About Cardiovascular System and Disorders
MARCH 30, 2024
Transcript of video: Hypoplastic Left Heart Syndrome is a very severe form of congenital heart disease, in which, the left ventricle, aorta and mitral and aortic valves are hypoplastic and valves may be atretic as well. It has a very poor survival. Norwood procedure is the first stage palliation for hypoplastic left heart syndrome, and a second stage palliaton, bidirectional Glenn procedure is done, to separate the pulmonary and systemic circulations, and finally, a Fontan procedure, Fontan type
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
All About Cardiovascular System and Disorders
MARCH 30, 2024
Transcipt of video: Mild tricuspid regurgitation is often noted on echocadiogram reports and sometimes causes a little bit of worry and a lot of questions are asked on mild tricuspid regurgitation. What is this mild tricuspid regurgitation? This is the schematic diagram of the heart in which you can see right atrium, right ventricle, left atrium, left ventricle, aorta and pulmonary artery.
HCPLive
MARCH 30, 2024
In this interview segment, Del Rosso further explores the steps patients and clinicians should take in considering the recent Valisure report on benzene risk for skincare products with benzoyl peroxide.
All About Cardiovascular System and Disorders
MARCH 30, 2024
Transcript of the video: Ebstein’s Anomaly is one of the cyanotic congenital heart disease in which survival to adult life is common. In Ebstein’s anomaly, there is downward or apical displacement of posterior and septal tricuspid leaflets. The anterior leaflet is not displaced, but is elongated to meet the other leaflets, so that when it closes, a loud sound, tricuspid sound, is produced, which is called as the sail sound.
Med Page Today
MARCH 30, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
Expert insights. Personalized for you.
124 
Let's personalize your content